CN104356164B - 一种化合物及其制备方法和用途 - Google Patents
一种化合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN104356164B CN104356164B CN201410512389.8A CN201410512389A CN104356164B CN 104356164 B CN104356164 B CN 104356164B CN 201410512389 A CN201410512389 A CN 201410512389A CN 104356164 B CN104356164 B CN 104356164B
- Authority
- CN
- China
- Prior art keywords
- compound
- weight portions
- thiophene
- thiosemicarbazides
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 8
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 6
- 201000007270 liver cancer Diseases 0.000 claims abstract description 6
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 72
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- 150000003583 thiosemicarbazides Chemical class 0.000 claims description 21
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 claims description 18
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 12
- BIXNGBXQRRXPLM-UHFFFAOYSA-K ruthenium(3+);trichloride;hydrate Chemical compound O.Cl[Ru](Cl)Cl BIXNGBXQRRXPLM-UHFFFAOYSA-K 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 201000000498 stomach carcinoma Diseases 0.000 claims description 5
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 4
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 claims 2
- 235000019441 ethanol Nutrition 0.000 claims 1
- YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 abstract description 15
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000000375 suspending agent Substances 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 229930007927 cymene Natural products 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N aminothiocarboxamide Natural products NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 1
- DHCWLIOIJZJFJE-UHFFFAOYSA-L dichlororuthenium Chemical compound Cl[Ru]Cl DHCWLIOIJZJFJE-UHFFFAOYSA-L 0.000 abstract 1
- 206010017758 gastric cancer Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 201000011549 stomach cancer Diseases 0.000 abstract 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 22
- 229930192474 thiophene Natural products 0.000 description 11
- 239000000460 chlorine Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- -1 organometallic ruthenium compound Chemical class 0.000 description 7
- ODEKYHUPQWAKDE-UHFFFAOYSA-N CC1=C(C=CC=C1)C(C)C.C1(=CC=CC=C1)NC(NN)=S Chemical compound CC1=C(C=CC=C1)C(C)C.C1(=CC=CC=C1)NC(NN)=S ODEKYHUPQWAKDE-UHFFFAOYSA-N 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000000118 anti-neoplastic effect Effects 0.000 description 5
- WWRCMNKATXZARA-UHFFFAOYSA-N 1-Isopropyl-2-methylbenzene Chemical compound CC(C)C1=CC=CC=C1C WWRCMNKATXZARA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910019891 RuCl3 Inorganic materials 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- OXACXUIQRLDCKR-UHFFFAOYSA-N CC1=CC=C(C=C1)C(C)C.C1(=CC=CC=C1)NC(NN)=S Chemical compound CC1=CC=C(C=C1)C(C)C.C1(=CC=CC=C1)NC(NN)=S OXACXUIQRLDCKR-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
细胞株 | SGC-7901 | BEL-7404 |
IC50(umol/mL) | 35.5±4.4 | 20.2±3.2 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410512389.8A CN104356164B (zh) | 2014-09-29 | 2014-09-29 | 一种化合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410512389.8A CN104356164B (zh) | 2014-09-29 | 2014-09-29 | 一种化合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104356164A CN104356164A (zh) | 2015-02-18 |
CN104356164B true CN104356164B (zh) | 2017-02-15 |
Family
ID=52523495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410512389.8A Active CN104356164B (zh) | 2014-09-29 | 2014-09-29 | 一种化合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104356164B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102964387A (zh) * | 2012-11-30 | 2013-03-13 | 广西师范学院 | 一种有机金属钌离子对化合物及其制备方法和用途 |
CN103113414A (zh) * | 2013-03-06 | 2013-05-22 | 广西中医药大学 | 一种芳基钌配合物及其制备方法和用途 |
-
2014
- 2014-09-29 CN CN201410512389.8A patent/CN104356164B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102964387A (zh) * | 2012-11-30 | 2013-03-13 | 广西师范学院 | 一种有机金属钌离子对化合物及其制备方法和用途 |
CN103113414A (zh) * | 2013-03-06 | 2013-05-22 | 广西中医药大学 | 一种芳基钌配合物及其制备方法和用途 |
Non-Patent Citations (2)
Title |
---|
2-甲酰噻吩缩氨基硫脲及其芳基钌配合物的合成、结构与抗癌活性研究;刘利锋等;《有机化学》;20130222;第854-859页 * |
Synthesis, crystal and electronic structure,anticancer activity of ruthenium(II) arene complexes with thiosemicarbazones;Wei Su et al.;《Appl. Organometal. Chem.》;20130411;第307-312页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104356164A (zh) | 2015-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103113414A (zh) | 一种芳基钌配合物及其制备方法和用途 | |
CN104016956A (zh) | 5,2′,4′-三羟基-7-甲基-3-烃基黄酮类似物及其制备方法和应用 | |
CN108659051A (zh) | 一种靶向于卵巢癌的高活性香豆素-铂(ii)配合物及其合成方法与应用 | |
CN103222970A (zh) | 不对称单羰基姜黄素类似物在制备抗肿瘤药物中的应用 | |
CN104016957A (zh) | 7-甲基-3-香叶基黄酮和7-甲基-3-异戊烯基黄酮及其制备方法和应用 | |
CN104356164B (zh) | 一种化合物及其制备方法和用途 | |
CN103864642B (zh) | 大黄酸衍生物及其合成方法和用途 | |
CN104987356A (zh) | 一种熊果酸-糖酵解抑制剂dca偶联物及其应用 | |
CN104262409B (zh) | 一种用于治疗肝癌的有机化合物及其制备方法和用途 | |
CN104003968A (zh) | 天然产物3-prenyl Iuteolin类似物(Ⅰ)/(Ⅱ)及其制备方法和应用 | |
CN110423254B (zh) | 一种具有不对称单取代香豆素四价铂结构化合物、制备方法及其在制备抗肿瘤药物中的应用 | |
CN110590778B (zh) | 3,10二对甲氧基苯基6,12二氮杂四高立方烷类化合物及合成方法和药物组合物 | |
CN103012394B (zh) | 一种罗丹宁衍生物及其制备方法 | |
CN108148080B (zh) | 金属有机金(iii)配合物及其合成方法和应用 | |
CN105061352A (zh) | 芳基哌嗪衍生物ⅲ及其盐、制备方法和用途 | |
CN104262405B (zh) | 一种苯基-2-缩n4-苯基氨基硫脲芳基钌配合物及其制备方法和用途 | |
CN104387422A (zh) | 一种叔丁氧乙酰基钌化合物及其制备方法和用途 | |
CN103833766B (zh) | 阿格拉滨二甲胺富马酸盐及其在药物制备中的用途 | |
CN104311539B (zh) | 一种吖啶酰腙类衍生物及其制备方法和用途 | |
CN104262331B (zh) | 一种吖啶酰腙类衍生物及其制备方法和用途 | |
CN103709135B (zh) | 呫吨酮衍生物及其制备方法和应用 | |
CN106866695A (zh) | 冬凌草甲素衍生物及其制备和应用 | |
US11571430B2 (en) | Platinum(II) ammine selenourea complexes and methods of treating cancer | |
CN113069451B (zh) | 一种吡咯-2-磺酰胺化合物的制备方法及其在制备抗肿瘤药物中的应用 | |
CN101684123B (zh) | 2-甲酰胺基噻吩并吡啶衍生物制备方法及医药用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210125 Address after: 710000 Shaanxi Xi'an economic and Technological Development Zone, Fengcheng four road, Ming Guang road, southeast corner of the new business building 1808 Patentee after: SHAANXI ZHUANYI INTELLECTUAL PROPERTY OPERATION Co.,Ltd. Address before: 530213 No. 13 Wuhe Avenue, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: Guangxi University of Chinese Medicine |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230110 Address after: Room 403-01, Block D, Software Park, No. 228, Nanyi Road, Dongying Development Zone, Shandong 257091 Patentee after: Dongying Zhengnuo Technology Service Co.,Ltd. Address before: 710000 Shaanxi Xi'an economic and Technological Development Zone, Fengcheng four road, Ming Guang road, southeast corner of the new business building 1808 Patentee before: SHAANXI ZHUANYI INTELLECTUAL PROPERTY OPERATION CO.,LTD. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150218 Assignee: Dongying HUANGSHENG Medical Instrument Co.,Ltd. Assignor: Dongying Zhengnuo Technology Service Co.,Ltd. Contract record no.: X2023980043974 Denomination of invention: A compound and its preparation method and use Granted publication date: 20170215 License type: Common License Record date: 20231027 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Dongying HUANGSHENG Medical Instrument Co.,Ltd. Assignor: Dongying Zhengnuo Technology Service Co.,Ltd. Contract record no.: X2023980043974 Date of cancellation: 20240517 |